Contact: Will Sansom
sansom@uthscsa.edu
210-567-2579
University of Texas Health Science Center at San Antonio

Veronica Galvan, Ph.D., University of Texas Health Science Center at San Antonio

Caption: Veronica Galvan, Ph.D., of the Barshop Institute at the University of Texas Health Science Center at San Antonio, co-authored a PLoS ONE paper that showed rapamycin treatment prevented learning and memory deficits in mice engineered to develop Alzheimer's disease.

Credit: UT Health Science Center San Antonio

Usage Restrictions: None

Related news release: A drug that extends life span prevents Alzheimer's deficits